Humana PT Raised to $91.00 at Deutsche Bank (HUM)
Analysts at Deutsche Bank hoisted their target price on shares of Humana (NYSE:HUM) from $86.00 to $91.00 in a research report issued to clients and investors on Tuesday, American Banking and Market News reports. The firm currently has a “hold” rating on the stock. Deutsche Bank’s price target points to a potential downside of 3.92% from the stock’s previous close.
Shares of Humana (NYSE:HUM) traded down 1.43% on Tuesday, hitting $93.355. 410,826 shares of the company’s stock traded hands. Humana has a 52-week low of $63.93 and a 52-week high of $99.85. The stock has a 50-day moving average of $94.97 and a 200-day moving average of $85.05. The company has a market cap of $14.607 billion and a P/E ratio of 10.08.
Humana (NYSE:HUM) last released its earnings data on Wednesday, July 31st. The company reported $2.63 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.46 by $0.17. The company had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.36 billion. During the same quarter in the previous year, the company posted $2.16 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis.
A number of other analysts have also recently weighed in on HUM. Analysts at JPMorgan Chase & Co. raised their price target on shares of Humana from $100.00 to $110.00 in a research note to investors on Thursday, September 5th. They now have an “overweight” rating on the stock. Separately, analysts at Zacks downgraded shares of Humana from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, September 4th. They now have a $99.00 price target on the stock. Finally, analysts at Cantor Fitzgerald raised their price target on shares of Humana from $90.00 to $105.00 in a research note to investors on Wednesday, August 14th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $97.21.
Humana Inc (NYSE:HUM) is a health care company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.